Decision Diagnostics Corp (DECN)

[Johnny_C]

Nons, you wrote;

In the past year DECN dropped from .05 to .02 (and now moving north of .02)

In the past year TAUG utilized a 75:1 Reverse Split to get to .02 (and now dropping south of .02)

Yes, very interesting...

Non, let's do a more accurate comparison. Taug did do a 1/75 reverse split, but DECN did a 1/80 reverse split, followed by a 1/4 reverse split and then moved to wipe out shareholders with 100 shares or less. There would be many DECN shareholders wiped out after that. Taug has not lost shareholder value since the reverse split, yet DECN wiped shareholders out after their reverse splits.

They both had auditor Independence Violations, but in DECN's case Bozo Berman knew or should have known that having his bookkeeper work for the auditor was a violation. One can say that TAUG should have known that the auditor should have rotated off, but the auditor did a merger and provided TAUG and the BOD that they were Independent.

TAUG sued the auditor and received about $2 mil in damages. DECN did nothing.

DECN has bragged about having products, employees and phone, yet was trading at 2 pennies with TAUG several months ago.

DECN came out with announcements that they are purportedly potentially white-labeling with CVS, Walgreens, and Walmart, and has a product in Pet Smart and the PPS barely hit .09. While TAUG launches a CBD gum and the PPS traded in the .30's and retraced now to the high teens and .20's. DECN, even with white-labeling has not broken through the massive insurance market for meters. Doctors do not know about DECN and patients usually take doctors advice on meters. DECN seemingly has terrible margins and very high expenses. Up until now, they had 3 customers, some apparently related parties. The CBD gum will on hundreds of NY countertops within weeks, we have direct relationships with CVS top management, the Walgreen family and huge distributors. The gum can also be teed up in different dosages for drug trials for a multitude of indications. Doctors and Chiropractors are very interested in the product and there are more products coming. DECN is using a dying technology with increased downward competitive pressure and new and better monitoring being developed. For DECN, they need a deal with Life scan because as a stand-alone company they will not attract long term investors without audited financials.

The company that DECN wanted to merge with, has audited financials and is in a massive market that will only get bigger. They also have a neat portfolio that could help with a larger M&A. But even if that portfolio doesn't work out, TAUG can raise whatever funds it needs to do an M&A because it is audited and because of relationships.

Make it a great day!